DANYELZA: cost and payments to doctors
What Medicare Part D paid pharmacies for DANYELZA, and the payments that named it as the associated drug or biological under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Y-mabs Therapeutics, Inc.?
Y-mabs Therapeutics, Inc. reported the most payments naming DANYELZA. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $743K
- Providers
- 408
- Transactions
- 694
- Average per transaction
- $1,071
The per-transaction average — $1,071 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 408 providers the average total is $1,822, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Y-mabs Therapeutics, Inc. | $743,421 | 100.0% |